about
Ovarian Cancer: The Fallopian Tube as the Site of Origin and Opportunities for PreventionThe Use of Human Epididymis 4 and Cancer Antigen 125 Tumor Markers in the Benign or Malignant Differential Diagnosis of Pelvic or Adnexal Masses.Primary Fallopian Tube Carcinoma: A Case Report and Literature ReviewFOXL2 molecular status in adult granulosa cell tumors of the ovary: A study of primary and metastatic caseshPaf1/PD2 interacts with OCT3/4 to promote self-renewal of ovarian cancer stem cells.The role of transvaginal ultrasonography for detecting ovarian cancer in an asymptomatic screening population: a systematic review.Abdominopelvic washings in gynecologic pathology: A comprehensive review.Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival of epithelial ovarian cancer: a systematic review and meta-analysis of observational studies.Cancer of the ovary, fallopian tube, and peritoneum: a population-based comparison of the prognostic factors and outcomes.Neutrophil-to-Lymphocyte Ratio Is a Potential Prognostic Biomarker in Patients with Ovarian Cancer: A Meta-Analysis.The Putative Role of TP53 Alterations and p53 Expression in Borderline Ovarian Tumors - Correlation with Clinicopathological Features and Prognosis: A Mini-Review.Impact of post-diagnostic statin use on ovarian cancer mortality: a systematic review and meta-analysis of observational studies.Prognostic significance of preoperative serum albumin in epithelial ovarian cancer patients: a systematic review and dose-response meta-analysis of observational studies.Second primary cancer after primary peritoneal, epithelial ovarian, and fallopian tubal cancer: a retrospective study
P2860
Q26747279-87EE48E7-14A3-4E1F-8672-2D9E09916BBAQ33572029-314B7DAD-8742-4003-8B06-822B5BF21399Q33889617-35FA6FE0-8B33-409D-ACE8-C0C25F5552D0Q37106535-32946589-E490-487B-A92D-A20A02D920A4Q37716449-2A880C44-96A8-48A8-B260-D74136F80987Q38867844-63213CC6-C418-4513-96DA-112F1203FA03Q38941768-BD57A236-50DE-4292-B399-A32D2B0B745EQ39250764-0CCFED1B-8B50-4D11-9AEB-70CF2A2DD721Q40226034-0E884CB6-FB0B-4CB0-AB4A-71FBEC75D5A0Q41320252-E8C33EE6-A8B8-4490-8108-F3FA6D62F285Q41721833-50C9FA84-6A4B-4E2B-A516-35685E47DA4AQ49907318-E52A6EE9-BA47-4A97-899E-3D3F6025C95BQ53282562-53097CD9-93BE-441C-8E36-9DEC42F83EA5Q57213867-757879A1-3414-467C-A80D-31A08896C648
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Cancer of the ovary, fallopian tube, and peritoneum.
@en
type
label
Cancer of the ovary, fallopian tube, and peritoneum.
@en
prefLabel
Cancer of the ovary, fallopian tube, and peritoneum.
@en
P2093
P2860
P1476
Cancer of the ovary, fallopian tube, and peritoneum.
@en
P2093
Christopher Crum
Jonathan S Berek
Michael Friedlander
P2860
P304
P356
10.1016/J.IJGO.2015.06.007
P478
131 Suppl 2
P577
2015-10-01T00:00:00Z